About Blood Cancer Discovery


Blood Cancer Discovery publishes high quality Research Articles representing major advances in basic, translational and clinical research of leukemia, lymphoma, myeloma, and associated diseases through a variety of lenses:

  • Conceptual understanding of hematological cancer transcriptional circuits, stem cell and differentiation, mutagenesis and clonal evolution, microenvironment, metabolism and immunity;
  • Defining molecular and cellular features of pathogenesis, therapy response and relapse, from preclinical disease models to high-dimensional clinical data landscapes;
  • New pharmacological, biological and living cell therapies, from preclinical proof-of-concept to clinical trials;
  • New diagnostic tools, prognostic, diagnostic and pharmacodynamic biomarkers, computational and machine learning approaches to personalized medicine.

Serving as a platform for conceptual synthesis of the existing knowledge and as a forum for diverse ideas shaping future research directions, the journal will publish Reviews, Perspectives and Commentaries on topics of broadest interest in hematooncology.

Manuscript Submission

Blood Cancer Discovery welcomes submissions of primary research, review and commentary article types as well as letters to the editor. For descriptions and length requirements of the article types available to submitting authors, see the journal’s Categories of Articles.

The AACR Journals all use a similar Editorial Process and adhere to the same overarching Editorial Policies, both of which are detailed in the Information for Authors. These instructions contain important guidelines on authorship, publishing ethics, availability of materials and data, and data analysis and reporting. Authors should be familiar with these instructions prior to submitting their work to the journal. Manuscripts are stringently reviewed for high standards of scientific merit, and only those that report results of novel, timely, and broadly-significant research are accepted for publication.

Submit your article to Blood Cancer Discovery  SmartSubmit

Journal Metrics

Blood Cancer Discovery metrics are not yet available.

Editors and Editorial Board

Editorial oversight of Blood Cancer Discovery and decisions on manuscripts submitted to the journal are the responsibility of the Editorial Board with support from journal staff. See Editorial Board for more information.

Copyright, Permissions and Access

Material published in Blood Cancer Discovery is covered and protected by copyright. Authors who wish to publish in the journal must formally transfer copyright to the AACR but are granted considerable reuse rights. The final typeset version of every published article is rendered freely accessible 12 months after publication. Authors who prefer for their article to be immediately freely accessible online may make this selection by paying an additional fee through the AACR AuthorChoice option. In addition, the AACR assists authors in satisfying major funder Open Access archiving mandates by depositing the accepted author version of their article in a designated public repository. For additional details about all these topics, see Copyright, Permissions and Access.

Publication Fees

Publication and color fees for Blood Cancer Discovery will be waived through December 31, 2020.

Journal Information

Paper requirements statement The journal will be printed on paper that meets the requirements of ANSI/NISO Z39.48-1992 (Permanence of Paper).

Back Issues and Single Issue Sales

Subject to availability, single or back issues of Blood Cancer Discovery may be purchased for $60 per copy in the U.S. or $65 per copy outside the U.S. For more information, contact:

AACR Publications Sales & Marketing Department
American Association for Cancer Research
615 Chestnut Street, 17th Floor
Philadelphia, PA 19106-4404
Phone: (215) 440-9300; or Toll Free: (855) 744-4667
E-mail: pubsales@aacr.org


Blood Cancer Discovery Editorial Office
American Association for Cancer Research  |  Publications Division
615 Chestnut Street  |  17th Floor  |  Philadelphia, PA 19106-4404
Phone: (215) 440-9300  |  Fax: (215) 440-9354  |  E-mail:  bloodcancerdiscov@aacr.org